Mentis Pharma Limited
Founded in 2002 and headquartered in Delhi, India.
2002 | Delhi (India) | Active
Mentis Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
About Mentis Pharma
Mentis Pharma Limited (MPL) is a Public Limited Indian Non-Government Company incorporated in India on 05 November 2002 and has a history of 22 years and three months. Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Tyagi, Inder Gandhi, and Sanjay Taneja serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239DL2002PLC117591
- Company No.
117591
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Nov 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Trading
Who are the key members and board of directors at Mentis Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Tyagi  | Director | 05-Nov-2002 | Current |
| Inder Gandhi | Director | 05-Nov-2002 | Current |
| Sanjay Taneja | Director | 05-Nov-2002 | Current |
Financial Performance of Mentis Pharma.
Mentis Pharma Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mentis Pharma?
In 2017, Mentis Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Winsome Laboratories LimitedAshok Tyagi, Inder Gandhi and 1 more are mutual person
Winsome Bioceuticals Private LimitedInder Gandhi and Sanjay Taneja are mutual person
- Joy Homes Llp
Ashok Tyagi is a mutual person
- Winsome Medicare Private Limited
Ashok Tyagi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mentis Pharma?
Unlock and access historical data on people associated with Mentis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mentis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mentis Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.